Whole-body MRI (WB-MRI) versus axial skeleton MRI (AS-MRI) to detect and measure bone metastases in prostate cancer (PCa)

[1] Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 765-781

[2] Parkin DM(2010)Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study Br J Cancer 102 249-254

[3] Steliarova-Foucher E(2008)Conventional treatments of localized prostate cancer Urology 2 S25-S35

[4] Evans S(2009)High-grade prostate cancer and finasteride BJU Int 65 S2-S7

[5] Metcalfe C(2005)The evolving role of chemotherapy in androgen-independent hormone-refractory prostate cancer Urology 3 27-40

[6] Patel B(2009)Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases Drug Des Devel Ther 75 54-58

[7] Zerbib M(1995)Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone Br J Urol 34 2191-2198

[8] Zelefsky MJ(1993)Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases J Nucl Med 25 3281-3287

[9] Higano CS(2007)Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies J Clin Oncol 101 1225-1232

[10] Carroll PR(2009)Imaging metastatic bone disease from carcinoma of the prostate Br J Cancer 5 434-444

[1] Ferlay J(2010)Estimates of cancer incidence and mortality in Europe in 2008 Eur J Cancer 46 765-781

[2] Parkin DM(2010)Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study Br J Cancer 102 249-254

[3] Steliarova-Foucher E(2008)Conventional treatments of localized prostate cancer Urology 2 S25-S35

[4] Evans S(2009)High-grade prostate cancer and finasteride BJU Int 65 S2-S7

[5] Metcalfe C(2005)The evolving role of chemotherapy in androgen-independent hormone-refractory prostate cancer Urology 3 27-40

[6] Patel B(2009)Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases Drug Des Devel Ther 75 54-58

[7] Zerbib M(1995)Magnetic resonance imaging for the diagnosis of prostate cancer metastatic to bone Br J Urol 34 2191-2198

[8] Zelefsky MJ(1993)Comparison of radionuclide bone scans and magnetic resonance imaging in detecting spinal metastases J Nucl Med 25 3281-3287

[9] Higano CS(2007)Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies J Clin Oncol 101 1225-1232

[10] Carroll PR(2009)Imaging metastatic bone disease from carcinoma of the prostate Br J Cancer 5 434-444